Ad is loading...
RGLFX
Price
$23.74
Change
-$0.25 (-1.04%)
Updated
Nov 15 closing price
RWICX
Price
$66.66
Change
-$0.71 (-1.05%)
Updated
Nov 15 closing price
Ad is loading...

RGLFX vs RWICX

Header iconRGLFX vs RWICX Comparison
Open Charts RGLFX vs RWICXBanner chart's image
American Funds Global Insight R-5
Price$23.74
Change-$0.25 (-1.04%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R3
Price$66.66
Change-$0.71 (-1.05%)
VolumeN/A
CapitalizationN/A
RGLFX vs RWICX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGLFX vs. RWICX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGLFX is a StrongBuy and RWICX is a Sell.

FUNDAMENTALS
Fundamentals
RWICX has more cash in the bank: 125B vs. RGLFX (14.8B). RWICX (1.43) and RGLFX (1.42) have matching dividends . RGLFX was incepted earlier than RWICX: RGLFX (5 years) vs RWICX (22 years). RWICX is a more actively managed with annual turnover of: 27.00 vs. RGLFX (23.00). RGLFX (250) and RWICX (250) have matching initial minimum investment requirements. RWICX annual gain was more profitable for investors over the last year : 18.74 vs. RGLFX (17.73). RGLFX return over 5 years is better than : 48.85 vs. RWICX (37.64).
RGLFXRWICXRGLFX / RWICX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years22 years-
Gain YTD10.77912.80584%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets14.8B125B12%
Annual Yield % from dividends1.421.4399%
Returns for 1 year17.7318.7495%
Returns for 3 years11.762.58455%
Returns for 5 years48.8537.64130%
Returns for 10 yearsN/A47.98-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USNA40.340.90
+2.28%
USANA Health Sciences
CXT55.490.20
+0.36%
Crane NXT Co
SVRE1.29-0.02
-1.80%
SaverOne 2014 Ltd
ILMN135.05-7.19
-5.05%
Illumina
ACRV6.96-0.96
-12.12%
Acrivon Therapeutics